Research summary, narrative review, 2026

Occupational Radiation Risk Stratification and Protection in Fluoroscopy-Guided Surgeons and Interventionalists: A Multispecialty Structured Narrative Review

Okraku-Yirenkyi NK, Bonthu SSR, Bhakta H, Duyile OO, Bernas M. Journal of personalized medicine. 2026

Read the original paper

In plain language

Across 16 studies of fluoroscopy-using surgeons and interventionalists, aprons, thyroid collars and lead glasses markedly cut measured dose, but glasses were often not worn. Cancer risk evidence is limited and mostly modeled, not directly observed.

At a glance

Type of study
Narrative review
Who was studied
Orthopedic surgeons, Vascular surgeons, Other surgeons, Interventional cardiologists, Interventional radiologists
Size
n = 16 studies
Where
United States, Italy, Japan, Ireland, South Korea
Summary based on
the full text

What it found

  • Lead aprons reduced operator exposure by about 90% at 0.25 mm and 99% at 0.5 mm; thyroid collars reduced neck dose 60-70%; lead glasses reduced eye dose 2.5-4.5-fold.

    Key figures: ~90% (0.25 mm), ~99% (0.5 mm); 60-70%; 2.5-4.5-fold

  • Unshielded operator doses averaged 0.08-0.11 mSv per procedure at the chest and 0.04-0.05 mSv at the eye.

    Key figures: 0.08-0.11 mSv chest; 0.04-0.05 mSv eye per procedure

  • Apron and thyroid collar compliance was high, but lead glasses were inconsistently used, often because they interfere with surgical loupes.

    Key figures: 90-99% compliance for aprons and collars

  • Limited epidemiologic data: one Italian study found 29% cancer incidence in exposed orthopedic surgeons versus 4% in controls; US data showed 2.9-fold higher breast cancer rate in female orthopedic surgeons.

    Key figures: 29% vs 4%; 2.9-fold

  • Biological Effects of Ionizing Radiation (BEIR) VII-based modeling projected lifetime attributable risk of all solid cancers for male surgeons of about 1 in 48; a relative risk of 3.2 was reported for posterior lens opacities.

    Key figures: 2079 per million (≈1 in 48); relative risk (RR) 3.2 (p < 0.005)

Limits to keep in mind

Narrative review of only 16 heterogeneous studies without meta-analysis; cancer evidence is sparse and largely modeled from BEIR VII and atomic bomb data that may not apply to chronic low-dose exposure, and nurses and technologists were not covered.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.